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Williams syndrome (WS) is a condition caused by a deletion of ∼26–28 genes on
chromosome 7q11.23 often characterized by abnormal social behavior and disrupted
oxytocin (OT) and vasopressin (AVP) functioning. The observation that individuals with WS
exhibit OT and AVP dysregulation is compelling. There is currently a lack of evidence that
any of the genes typically deleted in WS have any direct effect on either OT or AVP. In this
perspective article, we present a novel epigenetic model describing how DNA methylation
may impact the expression of key genes within the OT and AVP systems, which may
ultimately influence the social behavior observed in WS. We draw support from data
pooled from a prior empirical research study (Henrichsen et al., 2011), demonstrating that
OXTR is overexpressed in WS. These preliminary findings may create new opportunities
to target the OT and AVP systems with the specific goal of improving outcomes in WS and
other psychiatric conditions.
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OXYTOCIN, VASOPRESSIN, AND SOCIAL BEHAVIOR
Oxytocin (OT) and vasopressin (AVP) are neurohypophysial
hormones primarily synthesized within the hypothalamus of the
brain. Both OT and AVP are involved in the pathophysiology
for many psychiatric conditions that include autism, depression,
and anxiety (Meyer-Lindenberg et al., 2011; Ebstein et al., 2012).
For example, peripheral measures of OT are reduced in autism
(Modahl et al., 1998), and OT administration may reduce the
severity of symptoms in autism (Guastella et al., 2010). Accord-
ingly, there are clinical trials currently underway designed to test
the efficacy of OT administration on improving sociability and
communication in children and teens with autism. In spite of a
mass of empirical data showing that the OT and AVP systems
are perturbed in neurodevelopmental and mood disorders, the
mechanisms that lead to disrupted OT and AVP function are
currently unclear.
REGULATION OF OXYTOCIN AND VASOPRESSIN
EXPRESSION
One way to improve the understanding of the OT and AVP
systems is to investigate genes that influence the function of OT
and AVP. Some genes that impact OT and AVP function include
OXTR and AVPR1A, which encode the OT and AVP receptors,
respectively, throughout the brain and body (Kimura et al., 1992;
Inoue et al., 1994; Koshimizu et al., 2012). Expression profiles
and/or commonly occurring variants [e.g., single nucleotide poly-
morphisms (SNPs)] of OXTR and AVPR1A are associated with
individual differences in human social behavior, emotion pro-
cessing, and many psychiatric conditions. Thanseem et al. (2012)
showed reduced expression of OXTR in autism. SNPs of OXTR
are associated with brain reactivity to emotional stimuli (Haas
et al., 2013) and behavioral measures of empathy (Rodrigues
et al., 2009), trust (Krueger et al., 2012), and emotion recognition
(Lucht et al., 2013). Variation of AVPR1A expression is associated
with social behavior in prairie voles (Barrett et al., 2013). Com-
monly occurring polymorphic microsatellite repeats of AVPR1A
are associated with brain reactivity to emotional stimuli (Zink and
Meyer-Lindenberg, 2012) and behavioral measures of generosity
(Avinun et al., 2011), pair bonding (Walum et al., 2008), and harm
avoidance (Meyer-Lindenberg et al., 2008). Together, this research
indicates that OXTR and AVPR1A influence the function of the
OT and AVP systems, and thus affect social behavior and emotion
processing. It is currently unknown however, what mechanisms
contribute to altered expression of OXTR and AVPR1A genes.
A missing component within the puzzle that explains altered OT
and AVP functioning is a factor that impacts the expression of
genes within the OT and AVP systems.
In addition to DNA sequence variation, epigenetic mecha-
nisms can also influence OT and AVP expression. The field of
epigenetics seeks to understand how structural modifications to
DNA or its protein scaffolding, such as histone modification or
DNA methylation, regulate the expression of specific genes. Many
contemporary models of psychiatric illness embrace the concept
that epigenetic modifications influence the onset and severity of
specific symptoms (Smith et al., 2014). Thus, by understanding
the mechanisms that influence the activity and expression of
genes, a more complete, mechanistic view of many forms of
psychiatric illness can be reached. In this perspective article, we
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present a theoretical epigenetic model describing how a specific
set of social behaviors may be influenced by epigenetic processes
within the OT and AVP systems.
WILLIAMS SYNDROME, A UNIQUE WINDOW TO GENETIC
INFLUENCES ON THE SOCIAL AND EMOTIONAL BRAIN
Williams syndrome (WS) is a model system for understand-
ing genetic influences on social-emotional processing (Jarvinen-
Pasley et al., 2008). WS is caused by a deletion of∼26–28 genes on
chromosome 7q11.23 and is often paired with a distinctive social-
emotional profile characterized by reduced social inhibition, an
increased affinity toward attending to faces and a reduced sensi-
tivity to fear-related social stimuli (Martens et al., 2008; Haas and
Reiss, 2012). Because WS is caused by a genetic deletion, studying
this condition provides a rare opportunity to explore gene-brain-
social behavior associations in humans (Hoeft et al., 2014). More
specifically, by studying WS, evidence that specific genes impact
human social behavior and emotion processing can be obtained.
Several aspects of the WS social-emotional phenotype mirror
those typically associated with other neurodevelopmental condi-
tion, such as autism. One characteristic behavior associated with
WS is the tendency to be less socially inhibited and more trusting
of others as compared to typically developing (TD) controls.
For example, individuals with WS are more willing to approach
strangers (Dodd et al., 2010) and rate facial expressions as more
trustworthy or approachable (Jones et al., 2000; Martens et al.,
2012) relative to controls. People with WS also tend to exhibit
an abnormally high amount of attention toward social stimuli
such as faces. Studies using eye-tracking show that people with
WS fixate on faces longer (Riby and Hancock, 2008, 2009) and
are slower to disengage their gaze once fixated on eyes (Porter
et al., 2010) or a face (Riby et al., 2011) as compared to controls.
Lastly, individuals with WS tend to be less sensitive to fear-related
social stimuli than controls (Plesa-Skwerer et al., 2009). Together,
these findings suggest that biological systems involved in social-
emotional processing are affected by the deletion of genes in WS.
Several neuroimaging studies have demonstrated that key
brain regions involved in social-emotional processing are
functionally and structurally abnormal in WS. For example, func-
tional neuroimaging research shows that individuals with WS
exhibit larger areas of brain activation (within the fusiform face
area) when processing faces compared to controls (Golarai et al.,
2010). In addition, individuals with WS exhibit reduced amyg-
dala response to fearful facial expressions (Meyer-Lindenberg
et al., 2005), and increased amygdala response to happy facial
expressions (Haas et al., 2009). Structurally, individuals with WS
exhibit increased amygdala volume (Martens et al., 2009; Haas
et al., 2014b), and increased fractional anisotropy within the
amygdala and fusiform gyrus (Haas et al., 2014a) relative to TD
controls. These findings suggest that the genes deleted in WS may
influence the development of the human social and emotional
brain.
Recently, compelling evidence has emerged that the OT and
AVP systems are perturbed in WS (Dai et al., 2012). Dai et al.
(2012) collected blood plasma levels from a sample with WS and
TD controls at baseline and at multiple time points following a
positive emotional intervention (music), and a negative physical
stressor (cold). The results showed that OT and AVP levels were
increased in WS at baseline, and in response to psychological
manipulations (music and cold). Additionally, WS was associated
with greater variability in OT and AVP response as compared to
controls. These findings support the hypothesis that the regula-
tion of OT and AVP is altered in WS.
It is currently unknown what mechanisms impact altered OT
and AVP functioning in WS. There is currently no evidence
that genes that code for the synthesis, transmission or signal
transduction of OT or AVP are located within the “WS classic
deletion region.” This presents an intriguing question. Are there
other (possibly indirect) mechanisms through which the deleted
genes in WS can impact the function of the OT and AVP systems?
OXTR AND AVPR1A EXPRESSION
One factor that may impact OT and AVP functioning in WS
is altered expression of OXTR and AVPR1A. Prior studies have
shown abnormities in gene expression in WS, but have not
focused specifically on genes within the OT and AVP systems.
We evaluated gene expression data from a previously published
study on gene expression in WS (Henrichsen et al., 2011), using
the Gene Expression Omnibus (GEO)1, a public genomics data
repository. Data were selected and downloaded using GEO2R2,
an interactive web platform used to compare samples across
experimental conditions (GSE16715). Based on prior evidence
that OT and AVP are dysregulated in WS (Dai et al., 2012), we
compared expression of OXTR (ID: 206825_at) and AVPR1A (ID:
206250_x_at) between eight WS patients (mean age= 4.87 years;
standard deviation= 2.10) and nine age and sex matched healthy
controls (CNTL; M = 4.77; SD = 1.79; Figure 1). Within the
GEO2R, data for these two transcripts were extracted and ana-
lyzed using default settings (Benjamini–Hochberg—false discov-
ery rate and auto-detect for log transformation).
We found that the WS subjects exhibited greater expression of
OXTR (M = 10.22, SD = 0.68) compared to CNTLs (M = 7.86,
SD= 1.79) (t = 3.51, p= 0.003, 95% Confidence Interval= 0.93–
3.81) (Figure 1A). Though the mean expression of AVPR1A was
1ncbi.nlm.nih.gov/geo/
2ncbi.nlm.nih.gov/geo/info/geo2r.html
FIGURE 1 | Bar graphs displaying expression values for OXTR (A) and
AVPR1A (B) in Williams syndrome (WS) and healthy controls (CNTL).
Error bars represent standard error from the mean.
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FIGURE 2 | Schematic representation of epigenetic model describing DNA methylation and gene expression impacting altered social behavior in
Williams syndrome.
higher in WS, there was no statistical difference between the WS
(M = 3.84, SD= 0.11) and CNTL (M = 3.70, SD= 0.17) groups
(t = 1.97, p = 0.067, 95% CI = −0.01 to −0.29) (Figure 1B).
We observed that the variance was statistically different between
groups for OXTR expression (Levine’s test for Equality of Vari-
ances: F = 7.87, p = 0.013). Therefore we conduced a two-
sample t-test with equal variances not assumed and found that
the difference between groups remained statistically significant
for OXTR (t = 3.68, p= 0.004). The variance was not statistically
difference between groups for AVPR1A expression (Levine’s test
for Equality of Variances: F = 0.42, p = 0.53). Combined, these
data suggest that abnormal function of OT system in WS, may
in part be influenced by overexpression of OXTR. However, these
data do not provide any information in terms of factors that may
alter OT and AVP gene expression levels in WS.
COMBINED MODEL: ALTERED DNA METHYLATION AND
EXPRESSION OF OT AND AVP GENES IN WS
Gene expression is affected by many biochemical processes inclu-
ding transcription factors and DNA methylation. DNA methyla-
tion occurs when a methyl group forms a covalent attachment
with the 5′ carbon of cytosine in the context of a cytosine
phosphodiester guanine (CpG) dinucleotide, commonly called a
CpG site. DNA methylation regulates gene expression by influenc-
ing the recruitment and binding of regulatory protein to DNA.
Typically, an increase in DNA methylation at gene promoter
regions is associated with a decrease in expression of that gene
(Bonasio et al., 2010). Thought of in a different way; reduced
DNA methylation is typically associated with an increase in gene
expression.
As with the majority of biochemical processes, DNA methyla-
tion is regulated by a set of specific genes. For example, DNMT
genes (e.g., DMNT1, DMNT3a, DMNT3b) code for the produc-
tion of an enzyme called methyltransferase (Robertson et al.,
1999). Methyltransferase functions to transfer a methyl group
during DNA methylation. Disruption of DMNT1 is associated
with reduced levels of DNA methylation (Li et al., 1992) and an
over expression of other genes (Rhee et al., 2002). Together, this
leads to a novel question: are there any genes within the “WS
classic deletion region” implicated to regulate DNA methylation?
Identifying such genes may help to identify processes that impact
gene expression within the OT and AVP systems in WS.
One gene commonly deleted in WS (WBSCR22) is involved in
the production of methyltransferase (Doll and Grzeschik, 2001;
Merla et al., 2002). Williams–Beuren syndrome chromosome
region 22 (WBSCR22) is a gene deleted in WS that encodes a pro-
tein containing a nuclear localization signal and an S-adenosyl-L-
methionine binding motif typical of methyltransferases. Together,
the deletion WBSCR22 in WS may affect DNA methylation and
ultimately the expression of other genes.
The cause of disrupted OT and AVP functioning in many
psychiatric conditions, including WS, is currently not known. In
addition, it is not known if disrupted OT and AVP functioning is
either a cause or an effect of altered social behavior and emotion
processing in many conditions. Gene expression is regulated by a
variety of biochemical processes, and it is reasonable to hypoth-
esize that one of the genes in the WS deletion region regulates
OT and AVP. Indeed the genes in the WS deletion region have
widespread regulatory functions, and further characterization of
the genes in this region will be vital for understanding how this
deletion results in the cognitive and social characteristics typical
in WS patients. The preliminary data presented here suggest that
altered social behavior in WS may be influenced by overexpression
of OXTR (Figure 2), which may, in turn, result in dysregulation of
the OT systems.
IMPACT AND FUTURE DIRECTIONS
A fundamental goal of behavioral genetics, neuroscience and psy-
chology research is to understand how biological and mental pro-
cesses are perturbed. One useful approach to elucidating genetic
effects on abnormal functioning is to use “knock-out” animal
models. Studying genetic effects on behavior in animals provides
useful insight onto how specific genes impact other genetic,
biochemical, or psychological functions in animals. However, this
approach is extremely limited in terms of how findings from
animals can be translated to the complex array of psychosocial
processes that humans possess.
Empirical investigations of WS syndrome provide a unique
opportunity to overcome this challenge. WS is caused by the
deletion of a specify set of genes. Thus, studying WS holds the
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novel potential to associate the deletion of genes with downstream
effects on genetic, biochemical and/or psychological systems in
humans. Investigations of the genes of the WS deletion region or
genes implicated in the social symptoms common in WS patients,
including OXTR and AVPR1A, may only be observable in select
tissues. Gene expression supports tissue-specific functions, and
genes required for regulation of social function may only be
characterized in brain regions that support social function or in
relevant cell lines.
The pathophysiology underlying disrupted social-emotional
processing in WS mirrors the pathophysiology often associ-
ated with other neurodevelopmental conditions such as autism
(Tager-Flusberg et al., 2006). WS is characterized by an abnor-
mally increased drive toward social interaction, while autism
is characterized by a relative aversion toward social interac-
tion. These opposing tendencies in social-emotional processing
are also represented within the brain. For example, we have
shown that WS is characterized by abnormally increased amyg-
dala volume (Haas et al., 2014b), while autism is character-
ized by abnormally reduced amygdala volume (Nacewicz et al.,
2006). Additionally (as directly related to our current hypothe-
ses), WS is characterized by abnormally increased levels of OT
(Dai et al., 2012), while autism is characterized by abnormally
decreased levels of OT (Modahl et al., 1998). Lastly, there is
compelling evidence of common genetic mechanisms influencing
WS and autism. Specifically, while WS is caused by a deletion
of genes at 7q11.23, the duplication of genes at 7q11.23 is asso-
ciated with the presence of autistic symptoms (Sanders et al.,
2011).
Thus, studying key systems influencing disrupted social behav-
ior and emotional processing in WS has the important potential
to improve our understanding of the pathophysiology of other
neurodevelopmental conditions and in particular, autism. Inter-
estingly, recent evidence indicates that autism is associated with
abnormally increased DNA methylation of OXTR (Gregory et al.,
2009). Based on the apparent “mirroring” of phenotypes between
WS and autism, we predict to observe WS to be associated with
abnormally decreased methylation of OXTR. Together, obtaining
evidence that the deleted genes in WS influence the expression
of OT genes will provide substantial insight onto genetic and
biochemical factors that impact altered OT function in other
neurodevelopmental conditions.
These preliminary findings have a clear and direct potential
to improve treatment techniques for individuals with WS. For
example, there is evidence that altering OT levels impacts socia-
bility and communication in children and teens with autism. The
results of these clinical trials, in combination with the potential
results from this study, may contribute to the design of treatment
approaches that target the OT or AVP systems in WS.
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